Kawasaki disease pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Kawasaki disease}} {{CMG}}; {{AE}} ==Overview== The exact pathogenesis of [disease name] is not fully understood. OR It is thought that [disease name] is the r...")
 
No edit summary
 
(58 intermediate revisions by 4 users not shown)
Line 2: Line 2:
{{Kawasaki disease}}
{{Kawasaki disease}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SH}}, {{Sab}}
==Overview==
==Overview==
The exact pathogenesis of [disease name] is not fully understood.
The exact pathogenesis of Kawasaki disease is not fully understood. However, it is thought that Kawasaki disease is caused by either environmental, [[genetic]], or [[viral]] causes. Kawasaki disease is defined as the [[systemic inflammation]] of the medium sized arteries and in multiple [[Organ (anatomy)|organs]] and [[Tissue (biology)|tissues]], which can lead to associated conditions such as [[Hepatitis (patient information)|hepatitis]], [[interstitial pneumonitis]], [[abdominal pain]], [[vomiting]], [[diarrhea]], [[gallbladder]] hydrops, [[aseptic meningitis]], [[irritability]], [[myocarditis]], [[pericarditis]], [[valvulitis]], [[pyuria]], [[pancreatitis]], and [[lymphadenopathy]]. On [[gross pathology]], large or giant [[Coronary artery aneurysm|coronary artery aneurysms]], [[Thrombus|thrombi]] containing [[Aneurysm|aneurysms]], decreases in luminal diameter, [[stenosis]] of the lumen and chronic [[inflamation]] are noted. On [[microscopic]] [[histopathological]] [[analysis]] of [[Autopsy|autopsied]] cases of Kawasaki disease, intracytoplasmic [[inclusion bodies]] are frequently observed in [[ciliated]] [[Bronchiole|bronchial]] [[epithelial cells]].
 
OR
 
It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
 
OR
 
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
 
OR
 
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
 
OR
 
 
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
 
OR
 
The progression to [disease name] usually involves the [molecular pathway].
 
OR
 
The pathophysiology of [disease/malignancy] depends on the histological subtype.
 
==Pathophysiology==
==Pathophysiology==


===Pathogenesis===
===Pathogenesis===
*The exact pathogenesis of [disease name] is not fully understood.
 
OR
* The exact pathogenesis of Kawasaki disease is not fully understood.
*It is understood that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
* It is thought that Kawasaki disease is caused by either environmental, viral, or [[genetic|genetic mutations]] in [[FCGR2A]], [[CASP3]], [[HLA-A2|HLAclass II]], [[BLK (gene)|BLK]], IPTKC and [[CD40]].
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
*The progression to [disease name] usually involves the [molecular pathway].
*The pathophysiology of [disease/malignancy] depends on the histological subtype.


==Genetics==
==Genetics==
*[Disease name] is transmitted in [mode of genetic transmission] pattern.
In independent cohort studies, the genes which have been identified to lead to the development of Kawasaki disease include:<ref name="McCrindleRowley2017">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref>
*Genes involved in the pathogenesis of [disease name] include [gene1], [gene2], and [gene3].
{|
*The development of [disease name] is the result of multiple genetic mutations.
|-
| colspan="5" |<small>Adapted from the AHA Scientific Statement on the diagnosis, treatment, and long term management of Kawasaki disease</small><ref name="McCrindleRowley2017">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref>
|-
! style="background:#4479BA; color: #FFFFFF;" |Gene
! style="background:#4479BA; color: #FFFFFF;" |Chromosome Location
! style="background:#4479BA; color: #FFFFFF;" |Genetic Methods
! style="background:#4479BA; color: #FFFFFF;" |Validation Populations
! style="background:#4479BA; color: #FFFFFF;" |Potential Significance
|-
! style="background:#DCDCDC;" |[[FCGR2A]]<ref name="KhorDavila2011">{{cite journal|last1=Khor|first1=C. C.|last2=Davila|first2=S.|last3=Shimizu|first3=C.|last4=Sheng|first4=S.|last5=Matsubara|first5=T.|last6=Suzuki|first6=Y.|last7=Newburger|first7=J. W.|last8=Baker|first8=A.|last9=Burgner|first9=D.|last10=Breunis|first10=W.|last11=Kuijpers|first11=T.|last12=Wright|first12=V. J.|last13=Levin|first13=M.|last14=Hibberd|first14=M. L.|last15=Burns|first15=J. C.|title=Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease|journal=Journal of Medical Genetics|volume=48|issue=7|year=2011|pages=467–472|issn=0022-2593|doi=10.1136/jmg.2010.086611}}</ref>
| style="background:#DCDCDC;" |
* 1q23
| style="background:#DCDCDC;" |
* [[Genome-wide association study|GWAS]]
| style="background:#DCDCDC;" |
* European descent, Taiwanese, Koreans, Han Chinese
| style="background:#DCDCDC;" |
* Low-affinity receptor for [[Fc receptor|Fc]] fragment of [[Immunoglobulin G|IgG]]; risk [[allele]] has lower binding affinity
|-
! style="background:#DCDCDC;" |[[CASP3]]<ref name="OnouchiOzaki2010">{{cite journal|last1=Onouchi|first1=Yoshihiro|last2=Ozaki|first2=Kouichi|last3=Buns|first3=Jane C.|last4=Shimizu|first4=Chisato|last5=Hamada|first5=Hiromichi|last6=Honda|first6=Takafumi|last7=Terai|first7=Masaru|last8=Honda|first8=Akihito|last9=Takeuchi|first9=Takashi|last10=Shibuta|first10=Shoichi|last11=Suenaga|first11=Tomohiro|last12=Suzuki|first12=Hiroyuki|last13=Higashi|first13=Kouji|last14=Yasukawa|first14=Kumi|last15=Suzuki|first15=Yoichi|last16=Sasago|first16=Kumiko|last17=Kemmotsu|first17=Yasushi|last18=Takatsuki|first18=Shinichi|last19=Saji|first19=Tsutomu|last20=Yoshikawa|first20=Tetsushi|last21=Nagai|first21=Toshiro|last22=Hamamoto|first22=Kunihiro|last23=Kishi|first23=Fumio|last24=Ouchi|first24=Kazunobu|last25=Sato|first25=Yoshitake|last26=Newburger|first26=Jane W.|last27=Baker|first27=Annette L.|last28=Shulman|first28=Stanford T.|last29=Rowley|first29=Anne H.|last30=Yashiro|first30=Mayumi|last31=Nakamura|first31=Yoshikazu|last32=Wakui|first32=Keiko|last33=Fukushima|first33=Yoshimitsu|last34=Fujino|first34=Akihiro|last35=Tsunoda|first35=Tatsuhiko|last36=Kawasaki|first36=Tomisaku|last37=Hata|first37=Akira|last38=Nakamura|first38=Yusuke|last39=Tanaka|first39=Toshihiro|title=Common variants in CASP3 confer susceptibility to Kawasaki disease|journal=Human Molecular Genetics|volume=19|issue=14|year=2010|pages=2898–2906|issn=1460-2083|doi=10.1093/hmg/ddq176}}</ref>
| style="background:#DCDCDC;" |
* 4q34-35
| style="background:#DCDCDC;" |
* Linkage analysis
* Candidate gene study
| style="background:#DCDCDC;" |
* Japanese, Taiwanese, Koreans, Chinese, Euro-Americans
| style="background:#DCDCDC;" |
* Mediates [[apoptosis]] in immune cells and [[Cardiomyocyte|cardiomyocytes]]
* Risk [[allele]] decreases [[gene transcription]]
|-
! style="background:#DCDCDC;" |[[HLA-A2|HLAclass II]]<ref name="OnouchiOzaki2012">{{cite journal|last1=Onouchi|first1=Yoshihiro|last2=Ozaki|first2=Kouichi|last3=Burns|first3=Jane C|last4=Shimizu|first4=Chisato|last5=Terai|first5=Masaru|last6=Hamada|first6=Hiromichi|last7=Honda|first7=Takafumi|last8=Suzuki|first8=Hiroyuki|last9=Suenaga|first9=Tomohiro|last10=Takeuchi|first10=Takashi|last11=Yoshikawa|first11=Norishige|last12=Suzuki|first12=Yoichi|last13=Yasukawa|first13=Kumi|last14=Ebata|first14=Ryota|last15=Higashi|first15=Kouji|last16=Saji|first16=Tsutomu|last17=Kemmotsu|first17=Yasushi|last18=Takatsuki|first18=Shinichi|last19=Ouchi|first19=Kazunobu|last20=Kishi|first20=Fumio|last21=Yoshikawa|first21=Tetsushi|last22=Nagai|first22=Toshiro|last23=Hamamoto|first23=Kunihiro|last24=Sato|first24=Yoshitake|last25=Honda|first25=Akihito|last26=Kobayashi|first26=Hironobu|last27=Sato|first27=Junichi|last28=Shibuta|first28=Shoichi|last29=Miyawaki|first29=Masakazu|last30=Oishi|first30=Ko|last31=Yamaga|first31=Hironobu|last32=Aoyagi|first32=Noriyuki|last33=Iwahashi|first33=Seiji|last34=Miyashita|first34=Ritsuko|last35=Murata|first35=Yuji|last36=Sasago|first36=Kumiko|last37=Takahashi|first37=Atsushi|last38=Kamatani|first38=Naoyuki|last39=Kubo|first39=Michiaki|last40=Tsunoda|first40=Tatsuhiko|last41=Hata|first41=Akira|last42=Nakamura|first42=Yusuke|last43=Tanaka|first43=Toshihiro|title=A genome-wide association study identifies three new risk loci for Kawasaki disease|journal=Nature Genetics|volume=44|issue=5|year=2012|pages=517–521|issn=1061-4036|doi=10.1038/ng.2220}}</ref>
| style="background:#DCDCDC;" |
* 6p21.3
| style="background:#DCDCDC;" |
* [[Genome-wide association study|GWAS]]
| style="background:#DCDCDC;" |
* Japanese, Taiwanese, Koreans
| style="background:#DCDCDC;" |
* Activation marker for [[immune cells]]; [[antigen presentation]]
|-
! style="background:#DCDCDC;" |[[BLK (gene)|BLK]]<ref name="OnouchiOzaki20122">{{cite journal|last1=Onouchi|first1=Yoshihiro|last2=Ozaki|first2=Kouichi|last3=Burns|first3=Jane C|last4=Shimizu|first4=Chisato|last5=Terai|first5=Masaru|last6=Hamada|first6=Hiromichi|last7=Honda|first7=Takafumi|last8=Suzuki|first8=Hiroyuki|last9=Suenaga|first9=Tomohiro|last10=Takeuchi|first10=Takashi|last11=Yoshikawa|first11=Norishige|last12=Suzuki|first12=Yoichi|last13=Yasukawa|first13=Kumi|last14=Ebata|first14=Ryota|last15=Higashi|first15=Kouji|last16=Saji|first16=Tsutomu|last17=Kemmotsu|first17=Yasushi|last18=Takatsuki|first18=Shinichi|last19=Ouchi|first19=Kazunobu|last20=Kishi|first20=Fumio|last21=Yoshikawa|first21=Tetsushi|last22=Nagai|first22=Toshiro|last23=Hamamoto|first23=Kunihiro|last24=Sato|first24=Yoshitake|last25=Honda|first25=Akihito|last26=Kobayashi|first26=Hironobu|last27=Sato|first27=Junichi|last28=Shibuta|first28=Shoichi|last29=Miyawaki|first29=Masakazu|last30=Oishi|first30=Ko|last31=Yamaga|first31=Hironobu|last32=Aoyagi|first32=Noriyuki|last33=Iwahashi|first33=Seiji|last34=Miyashita|first34=Ritsuko|last35=Murata|first35=Yuji|last36=Sasago|first36=Kumiko|last37=Takahashi|first37=Atsushi|last38=Kamatani|first38=Naoyuki|last39=Kubo|first39=Michiaki|last40=Tsunoda|first40=Tatsuhiko|last41=Hata|first41=Akira|last42=Nakamura|first42=Yusuke|last43=Tanaka|first43=Toshihiro|title=A genome-wide association study identifies three new risk loci for Kawasaki disease|journal=Nature Genetics|volume=44|issue=5|year=2012|pages=517–521|issn=1061-4036|doi=10.1038/ng.2220}}</ref>
| style="background:#DCDCDC;" |
* 8p23-22
| style="background:#DCDCDC;" |
* [[Genome-wide association study|GWAS]]
| style="background:#DCDCDC;" |
* Japanese, Taiwanese, Koreans
| style="background:#DCDCDC;" |
* [[B-cell]] receptor [[signal transduction]]
|-
! style="background:#DCDCDC;" |IPTKC<ref name="OnouchiGunji2007">{{cite journal|last1=Onouchi|first1=Yoshihiro|last2=Gunji|first2=Tomohiko|last3=Burns|first3=Jane C|last4=Shimizu|first4=Chisato|last5=Newburger|first5=Jane W|last6=Yashiro|first6=Mayumi|last7=Nakamura|first7=Yoshikazu|last8=Yanagawa|first8=Hiroshi|last9=Wakui|first9=Keiko|last10=Fukushima|first10=Yoshimitsu|last11=Kishi|first11=Fumio|last12=Hamamoto|first12=Kunihiro|last13=Terai|first13=Masaru|last14=Sato|first14=Yoshitake|last15=Ouchi|first15=Kazunobu|last16=Saji|first16=Tsutomu|last17=Nariai|first17=Akiyoshi|last18=Kaburagi|first18=Yoichi|last19=Yoshikawa|first19=Tetsushi|last20=Suzuki|first20=Kyoko|last21=Tanaka|first21=Takeo|last22=Nagai|first22=Toshiro|last23=Cho|first23=Hideo|last24=Fujino|first24=Akihiro|last25=Sekine|first25=Akihiro|last26=Nakamichi|first26=Reiichiro|last27=Tsunoda|first27=Tatsuhiko|last28=Kawasaki|first28=Tomisaku|last29=Nakamura|first29=Yusuke|last30=Hata|first30=Akira|title=ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms|journal=Nature Genetics|volume=40|issue=1|year=2007|pages=35–42|issn=1061-4036|doi=10.1038/ng.2007.59}}</ref>
| style="background:#DCDCDC;" |
* 19q13.2
| style="background:#DCDCDC;" |
* Linkage analysis
* [[Transmission disequilibrium test|TDT]]
| style="background:#DCDCDC;" |
* Japanese, Taiwanese, Koreans, Chinese, Euro- Americans
| style="background:#DCDCDC;" |
* Negative regulator of [[calcineurin]]-[[NFAT]] signaling pathway; risk [[allele]] increases signaling
|-
! style="background:#DCDCDC;" |[[CD40]]<ref name="OnouchiOzaki20123">{{cite journal|last1=Onouchi|first1=Yoshihiro|last2=Ozaki|first2=Kouichi|last3=Burns|first3=Jane C|last4=Shimizu|first4=Chisato|last5=Terai|first5=Masaru|last6=Hamada|first6=Hiromichi|last7=Honda|first7=Takafumi|last8=Suzuki|first8=Hiroyuki|last9=Suenaga|first9=Tomohiro|last10=Takeuchi|first10=Takashi|last11=Yoshikawa|first11=Norishige|last12=Suzuki|first12=Yoichi|last13=Yasukawa|first13=Kumi|last14=Ebata|first14=Ryota|last15=Higashi|first15=Kouji|last16=Saji|first16=Tsutomu|last17=Kemmotsu|first17=Yasushi|last18=Takatsuki|first18=Shinichi|last19=Ouchi|first19=Kazunobu|last20=Kishi|first20=Fumio|last21=Yoshikawa|first21=Tetsushi|last22=Nagai|first22=Toshiro|last23=Hamamoto|first23=Kunihiro|last24=Sato|first24=Yoshitake|last25=Honda|first25=Akihito|last26=Kobayashi|first26=Hironobu|last27=Sato|first27=Junichi|last28=Shibuta|first28=Shoichi|last29=Miyawaki|first29=Masakazu|last30=Oishi|first30=Ko|last31=Yamaga|first31=Hironobu|last32=Aoyagi|first32=Noriyuki|last33=Iwahashi|first33=Seiji|last34=Miyashita|first34=Ritsuko|last35=Murata|first35=Yuji|last36=Sasago|first36=Kumiko|last37=Takahashi|first37=Atsushi|last38=Kamatani|first38=Naoyuki|last39=Kubo|first39=Michiaki|last40=Tsunoda|first40=Tatsuhiko|last41=Hata|first41=Akira|last42=Nakamura|first42=Yusuke|last43=Tanaka|first43=Toshihiro|title=A genome-wide association study identifies three new risk loci for Kawasaki disease|journal=Nature Genetics|volume=44|issue=5|year=2012|pages=517–521|issn=1061-4036|doi=10.1038/ng.2220}}</ref>
| style="background:#DCDCDC;" |
* 20q12-13.2
| style="background:#DCDCDC;" |
* [[Genome-wide association study|GWAS]]
| style="background:#DCDCDC;" |
* Japanese, Taiwanese, Koreans
| style="background:#DCDCDC;" |
* Risk alleles associated with increased [[Translation (genetics)|translation]]
|-
| colspan="5" |'''Abbreviations''': [[BLK (gene)|BLK]]; [[B cell|B-cell]] lymphoid kinase, [[CASP3]];[[Caspase 3]], [[FCGR1A|FCGR]]; Fcγ receptor, [[Genome-wide association study|GWAS]]; [[Genome-wide association study]], [[Human leukocyte antigen|HLA]]; [[human leukocyte antigen]], [[Immunoglobulin G|IgG]]; [[immunoglobulin G]], [[ITPKC]]; [[Inositol 1,4,5-triphosphate|inositol 1,4,5-trisphosphate kinase-C]], [[Kawasaki disease|KD; Kawasaki disease]], [[NFAT|NFAT; nuclear factor of activated T cells]], and [[Transmission disequilibrium test|TDT; transmission disequilibrium test.]]
|}


==Associated Conditions==
==Associated Conditions==
*Inflammation of the coronary arteries leads to the most important clinical outcomes.<ref name="McCrindleRowley20172">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref><ref name="pmid41111">{{cite journal |vauthors=Amano S, Hazama F, Hamashima Y |title=Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes |journal=Jpn. Circ. J. |volume=43 |issue=7 |pages=633–43 |date=July 1979 |pmid=41111 |doi= |url=}}</ref>
*Kawasaki disease is defined by the systemic inflammation of the medium-sized arteries, multiple organs and tissues.
*The systemic inflammation of the medium-sized arteries, organs and tissues can lead to the following associated conditions:
{|
! style="background:#4479BA; color: #FFFFFF;" |Organ and Tissue
! style="background:#4479BA; color: #FFFFFF;" |Associated conditions
|-
! style="background:#DCDCDC;" |[[Liver]]
| style="background:#DCDCDC;" |
* [[Hepatitis]]
|-
! style="background:#DCDCDC;" |[[Lung]]
| style="background:#DCDCDC;" |
* [[Interstitial pneumonitis]]
|-
! style="background:#DCDCDC;" |[[Gastrointestinal tract]]
| style="background:#DCDCDC;" |
* [[Abdominal pain]]
* [[Diarrhea]]
* [[Vomiting]]
* [[Gallbladder]] hydrops
|-
! style="background:#DCDCDC;" |[[Meninges]]
| style="background:#DCDCDC;" |
* [[Aseptic meningitis]]
* [[Irritability]]
|-
! style="background:#DCDCDC;" |[[Heart]]
| style="background:#DCDCDC;" |
* [[Myocarditis]]
* [[Pericarditis]]
* [[Valvulitis]]
|-
! style="background:#DCDCDC;" |[[Urinary tract]]
| style="background:#DCDCDC;" |
* [[Pyuria]]
|-
! style="background:#DCDCDC;" |[[Pancreas]]
| style="background:#DCDCDC;" |
* [[Pancreatitis]]
|-
! style="background:#DCDCDC;" |[[Lymph node|Lymph nodes]]
| style="background:#DCDCDC;" |
* [[Lymphadenopathy]]
|}


==Gross Pathology==
==Gross Pathology==
*On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
*On gross pathology, large or giant [[Coronary artery aneurysm|coronary artery aneurysms]], [[Thrombus|thrombi]] containing [[Aneurysm|aneurysms]], decreases luminal diameter, [[stenosis]] of the lumen and chronic inflammation are the usual findings of Kawasaki disease.<ref name="McCrindleRowley20173">{{cite journal|last1=McCrindle|first1=Brian W.|last2=Rowley|first2=Anne H.|last3=Newburger|first3=Jane W.|last4=Burns|first4=Jane C.|last5=Bolger|first5=Anne F.|last6=Gewitz|first6=Michael|last7=Baker|first7=Annette L.|last8=Jackson|first8=Mary Anne|last9=Takahashi|first9=Masato|last10=Shah|first10=Pinak B.|last11=Kobayashi|first11=Tohru|last12=Wu|first12=Mei-Hwan|last13=Saji|first13=Tsutomu T.|last14=Pahl|first14=Elfriede|title=Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association|journal=Circulation|volume=135|issue=17|year=2017|pages=e927–e999|issn=0009-7322|doi=10.1161/CIR.0000000000000484}}</ref>
*Kawasaki disease mainly involves the muscular arteries and is characterized by the following processes:
**[[Necrosis|Necrotizing]] [[arteritis]]
**Subacute [[vasculitis]]
**Chronic [[vasculitis]]
**Luminal [[Myofibroblast|myofibroblastic]] proliferation
===Images===
[[File:Kawasaki symptoms D.jpg|300px|thumb|left| Erythema of the palms, which is often accompanied by painful, brawny edema of the dorsa of the hands.<ref>By Kawasaki_symptoms.jpg: Dong Soo Kimderivative work: Natr (talk) - Kawasaki_symptoms.jpg, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=12776158</ref>]]
[[File:Kawasaki tongue.jpg|300px|thumb|center| Strawberry tongue and bright red, swollen lips with vertical cracking and bleeding.<ref>By Kawasaki_symptoms.jpg: Dong Soo Kimderivative work: Natr (talk) - Kawasaki_symptoms.jpg, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=12776137</ref>]]
[[File:Kawasaki.png|800px|left|thumb| (A) Bilateral, non-exudative conjunctival injection with perilimbal sparing. (B) Strawberry tongue and bright red, swollen lips with vertical cracking and bleeding. (C) Erythematous rash involving perineum. (D) Erythema of the palms, which is often accompanied by painful, brawny edema of the dorsa of the hands. (E) Erythema of the soles, and swelling dorsa of the feet. (F) Desquamation of the fingers. (G) Erythema and induration at the site of a previous vaccination with Bacille Calmette-Gurin (BCG). (H) Perianal erythematous desquamation.<ref>By Dong Soo Kim - Kawasaki disease., CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=9962875</ref>]]
<br style="clear:left">


==Microscopic Pathology==
==Microscopic Pathology==
*On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
*On microscopic histopathological analysis of autopsied cases of Kawasaki disease, intracytoplasmic [[inclusion bodies]] are frequently observed in [[ciliated]] [[Bronchiole|bronchial]] [[epithelial cells]].<ref name="pmid18270572">{{cite journal |vauthors=Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM |title=RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease |journal=PLoS ONE |volume=3 |issue=2 |pages=e1582 |date=February 2008 |pmid=18270572 |pmc=2216059 |doi=10.1371/journal.pone.0001582 |url=}}</ref>
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 61: Line 158:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
[[Category:Pediatrics]]
[[Category:Cardiovascular diseases]]
[[Category:Angiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]
[[Category:Dermatology]]
[[Category:Emergency medicine]]
[[Category:Up-To-Date]]

Latest revision as of 20:53, 12 February 2020

Kawasaki disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kawasaki disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kawasaki disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kawasaki disease pathophysiology

CDC on Kawasaki disease pathophysiology

Kawasaki disease pathophysiology in the news

Blogs on Kawasaki disease pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Kawasaki disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2], Sabawoon Mirwais, M.B.B.S, M.D.[3]

Overview

The exact pathogenesis of Kawasaki disease is not fully understood. However, it is thought that Kawasaki disease is caused by either environmental, genetic, or viral causes. Kawasaki disease is defined as the systemic inflammation of the medium sized arteries and in multiple organs and tissues, which can lead to associated conditions such as hepatitis, interstitial pneumonitis, abdominal pain, vomiting, diarrhea, gallbladder hydrops, aseptic meningitis, irritability, myocarditis, pericarditis, valvulitis, pyuria, pancreatitis, and lymphadenopathy. On gross pathology, large or giant coronary artery aneurysms, thrombi containing aneurysms, decreases in luminal diameter, stenosis of the lumen and chronic inflamation are noted. On microscopic histopathological analysis of autopsied cases of Kawasaki disease, intracytoplasmic inclusion bodies are frequently observed in ciliated bronchial epithelial cells.

Pathophysiology

Pathogenesis

Genetics

In independent cohort studies, the genes which have been identified to lead to the development of Kawasaki disease include:[1]

Adapted from the AHA Scientific Statement on the diagnosis, treatment, and long term management of Kawasaki disease[1]
Gene Chromosome Location Genetic Methods Validation Populations Potential Significance
FCGR2A[2]
  • 1q23
  • European descent, Taiwanese, Koreans, Han Chinese
  • Low-affinity receptor for Fc fragment of IgG; risk allele has lower binding affinity
CASP3[3]
  • 4q34-35
  • Linkage analysis
  • Candidate gene study
  • Japanese, Taiwanese, Koreans, Chinese, Euro-Americans
HLAclass II[4]
  • 6p21.3
  • Japanese, Taiwanese, Koreans
BLK[5]
  • 8p23-22
  • Japanese, Taiwanese, Koreans
IPTKC[6]
  • 19q13.2
  • Linkage analysis
  • TDT
  • Japanese, Taiwanese, Koreans, Chinese, Euro- Americans
CD40[7]
  • 20q12-13.2
  • Japanese, Taiwanese, Koreans
Abbreviations: BLK; B-cell lymphoid kinase, CASP3;Caspase 3, FCGR; Fcγ receptor, GWAS; Genome-wide association study, HLA; human leukocyte antigen, IgG; immunoglobulin G, ITPKC; inositol 1,4,5-trisphosphate kinase-C, KD; Kawasaki disease, NFAT; nuclear factor of activated T cells, and TDT; transmission disequilibrium test.

Associated Conditions

  • Inflammation of the coronary arteries leads to the most important clinical outcomes.[8][9]
  • Kawasaki disease is defined by the systemic inflammation of the medium-sized arteries, multiple organs and tissues.
  • The systemic inflammation of the medium-sized arteries, organs and tissues can lead to the following associated conditions:
Organ and Tissue Associated conditions
Liver
Lung
Gastrointestinal tract
Meninges
Heart
Urinary tract
Pancreas
Lymph nodes

Gross Pathology

Images

Erythema of the palms, which is often accompanied by painful, brawny edema of the dorsa of the hands.[11]
Strawberry tongue and bright red, swollen lips with vertical cracking and bleeding.[12]
(A) Bilateral, non-exudative conjunctival injection with perilimbal sparing. (B) Strawberry tongue and bright red, swollen lips with vertical cracking and bleeding. (C) Erythematous rash involving perineum. (D) Erythema of the palms, which is often accompanied by painful, brawny edema of the dorsa of the hands. (E) Erythema of the soles, and swelling dorsa of the feet. (F) Desquamation of the fingers. (G) Erythema and induration at the site of a previous vaccination with Bacille Calmette-Gurin (BCG). (H) Perianal erythematous desquamation.[13]


Microscopic Pathology

References

  1. ↑ 1.0 1.1 McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
  2. ↑ Khor, C. C.; Davila, S.; Shimizu, C.; Sheng, S.; Matsubara, T.; Suzuki, Y.; Newburger, J. W.; Baker, A.; Burgner, D.; Breunis, W.; Kuijpers, T.; Wright, V. J.; Levin, M.; Hibberd, M. L.; Burns, J. C. (2011). "Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease". Journal of Medical Genetics. 48 (7): 467–472. doi:10.1136/jmg.2010.086611. ISSN 0022-2593.
  3. ↑ Onouchi, Yoshihiro; Ozaki, Kouichi; Buns, Jane C.; Shimizu, Chisato; Hamada, Hiromichi; Honda, Takafumi; Terai, Masaru; Honda, Akihito; Takeuchi, Takashi; Shibuta, Shoichi; Suenaga, Tomohiro; Suzuki, Hiroyuki; Higashi, Kouji; Yasukawa, Kumi; Suzuki, Yoichi; Sasago, Kumiko; Kemmotsu, Yasushi; Takatsuki, Shinichi; Saji, Tsutomu; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Kishi, Fumio; Ouchi, Kazunobu; Sato, Yoshitake; Newburger, Jane W.; Baker, Annette L.; Shulman, Stanford T.; Rowley, Anne H.; Yashiro, Mayumi; Nakamura, Yoshikazu; Wakui, Keiko; Fukushima, Yoshimitsu; Fujino, Akihiro; Tsunoda, Tatsuhiko; Kawasaki, Tomisaku; Hata, Akira; Nakamura, Yusuke; Tanaka, Toshihiro (2010). "Common variants in CASP3 confer susceptibility to Kawasaki disease". Human Molecular Genetics. 19 (14): 2898–2906. doi:10.1093/hmg/ddq176. ISSN 1460-2083.
  4. ↑ Onouchi, Yoshihiro; Ozaki, Kouichi; Burns, Jane C; Shimizu, Chisato; Terai, Masaru; Hamada, Hiromichi; Honda, Takafumi; Suzuki, Hiroyuki; Suenaga, Tomohiro; Takeuchi, Takashi; Yoshikawa, Norishige; Suzuki, Yoichi; Yasukawa, Kumi; Ebata, Ryota; Higashi, Kouji; Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi; Ouchi, Kazunobu; Kishi, Fumio; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Sato, Yoshitake; Honda, Akihito; Kobayashi, Hironobu; Sato, Junichi; Shibuta, Shoichi; Miyawaki, Masakazu; Oishi, Ko; Yamaga, Hironobu; Aoyagi, Noriyuki; Iwahashi, Seiji; Miyashita, Ritsuko; Murata, Yuji; Sasago, Kumiko; Takahashi, Atsushi; Kamatani, Naoyuki; Kubo, Michiaki; Tsunoda, Tatsuhiko; Hata, Akira; Nakamura, Yusuke; Tanaka, Toshihiro (2012). "A genome-wide association study identifies three new risk loci for Kawasaki disease". Nature Genetics. 44 (5): 517–521. doi:10.1038/ng.2220. ISSN 1061-4036.
  5. ↑ Onouchi, Yoshihiro; Ozaki, Kouichi; Burns, Jane C; Shimizu, Chisato; Terai, Masaru; Hamada, Hiromichi; Honda, Takafumi; Suzuki, Hiroyuki; Suenaga, Tomohiro; Takeuchi, Takashi; Yoshikawa, Norishige; Suzuki, Yoichi; Yasukawa, Kumi; Ebata, Ryota; Higashi, Kouji; Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi; Ouchi, Kazunobu; Kishi, Fumio; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Sato, Yoshitake; Honda, Akihito; Kobayashi, Hironobu; Sato, Junichi; Shibuta, Shoichi; Miyawaki, Masakazu; Oishi, Ko; Yamaga, Hironobu; Aoyagi, Noriyuki; Iwahashi, Seiji; Miyashita, Ritsuko; Murata, Yuji; Sasago, Kumiko; Takahashi, Atsushi; Kamatani, Naoyuki; Kubo, Michiaki; Tsunoda, Tatsuhiko; Hata, Akira; Nakamura, Yusuke; Tanaka, Toshihiro (2012). "A genome-wide association study identifies three new risk loci for Kawasaki disease". Nature Genetics. 44 (5): 517–521. doi:10.1038/ng.2220. ISSN 1061-4036.
  6. ↑ Onouchi, Yoshihiro; Gunji, Tomohiko; Burns, Jane C; Shimizu, Chisato; Newburger, Jane W; Yashiro, Mayumi; Nakamura, Yoshikazu; Yanagawa, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Kishi, Fumio; Hamamoto, Kunihiro; Terai, Masaru; Sato, Yoshitake; Ouchi, Kazunobu; Saji, Tsutomu; Nariai, Akiyoshi; Kaburagi, Yoichi; Yoshikawa, Tetsushi; Suzuki, Kyoko; Tanaka, Takeo; Nagai, Toshiro; Cho, Hideo; Fujino, Akihiro; Sekine, Akihiro; Nakamichi, Reiichiro; Tsunoda, Tatsuhiko; Kawasaki, Tomisaku; Nakamura, Yusuke; Hata, Akira (2007). "ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms". Nature Genetics. 40 (1): 35–42. doi:10.1038/ng.2007.59. ISSN 1061-4036.
  7. ↑ Onouchi, Yoshihiro; Ozaki, Kouichi; Burns, Jane C; Shimizu, Chisato; Terai, Masaru; Hamada, Hiromichi; Honda, Takafumi; Suzuki, Hiroyuki; Suenaga, Tomohiro; Takeuchi, Takashi; Yoshikawa, Norishige; Suzuki, Yoichi; Yasukawa, Kumi; Ebata, Ryota; Higashi, Kouji; Saji, Tsutomu; Kemmotsu, Yasushi; Takatsuki, Shinichi; Ouchi, Kazunobu; Kishi, Fumio; Yoshikawa, Tetsushi; Nagai, Toshiro; Hamamoto, Kunihiro; Sato, Yoshitake; Honda, Akihito; Kobayashi, Hironobu; Sato, Junichi; Shibuta, Shoichi; Miyawaki, Masakazu; Oishi, Ko; Yamaga, Hironobu; Aoyagi, Noriyuki; Iwahashi, Seiji; Miyashita, Ritsuko; Murata, Yuji; Sasago, Kumiko; Takahashi, Atsushi; Kamatani, Naoyuki; Kubo, Michiaki; Tsunoda, Tatsuhiko; Hata, Akira; Nakamura, Yusuke; Tanaka, Toshihiro (2012). "A genome-wide association study identifies three new risk loci for Kawasaki disease". Nature Genetics. 44 (5): 517–521. doi:10.1038/ng.2220. ISSN 1061-4036.
  8. ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
  9. ↑ Amano S, Hazama F, Hamashima Y (July 1979). "Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes". Jpn. Circ. J. 43 (7): 633–43. PMID 41111.
  10. ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.
  11. ↑ By Kawasaki_symptoms.jpg: Dong Soo Kimderivative work: Natr (talk) - Kawasaki_symptoms.jpg, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=12776158
  12. ↑ By Kawasaki_symptoms.jpg: Dong Soo Kimderivative work: Natr (talk) - Kawasaki_symptoms.jpg, CC BY 2.0, https://commons.wikimedia.org/w/index.php?curid=12776137
  13. ↑ By Dong Soo Kim - Kawasaki disease., CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=9962875
  14. ↑ Rowley AH, Baker SC, Shulman ST, Garcia FL, Fox LM, Kos IM, Crawford SE, Russo PA, Hammadeh R, Takahashi K, Orenstein JM (February 2008). "RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease". PLoS ONE. 3 (2): e1582. doi:10.1371/journal.pone.0001582. PMC 2216059. PMID 18270572.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Kawasaki_disease_pathophysiology&oldid=1598614"